Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins “Squawk Box” to discuss how he thinks companies should go about pricing the Covid-19 vaccine once it becomes available.
Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins “Squawk Box” to discuss how he thinks companies should go about pricing the Covid-19 vaccine once it becomes available.
